Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.
Transplantation. 2024 Feb 1;108(2):516-523. doi: 10.1097/TP.0000000000004801. Epub 2023 Sep 11.
Thoracoabdominal normothermic regional perfusion (TA-NRP) has been increasingly used for donation after circulatory death (DCD) procurements in the United States. We present the largest report of outcomes of kidney transplants performed using DCD donor grafts perfused with TA-NRP.
Adult DCD kidney transplants between 2020 and 2022 in the United Network for Organ Sharing database were included. Donors with ≥50 min between asystole and aortic cross-clamp time in which the heart was also transplanted were considered TA-NRP donors. All other donors were considered direct recovery donors. Multivariable regressions were used to assess delayed graft function, as well as posttransplant survival and all-cause graft failure at 30, 90, and 180 d. A propensity-matched analysis of cohorts matched on donor Kidney Donor Profile Index was performed.
Of the 16 140 total DCD kidney transplants performed during the study period, 306 (1.9%) used TA-NRP. TA-NRP donors were younger ( P < 0.001) and had lower Kidney Donor Profile Index ( P < 0.001) compared with direct recovery donors. Recipients receiving grafts recovered using TA-NRP were younger ( P < 0.001) and more likely to be blood group O ( P < 0.001). Transplants using TA-NRP had lower likelihood of delayed graft function (adjusted odds ratio 0.22 [95% confidence interval, 0.15-0.31], P < 0.001) but similar 180-d survival ( P = 0.8) and all-cause graft failure ( P = 0.3) as transplants using direct recovery grafts. These inferences were unchanged on propensity-matched analysis.
Our results demonstrate that kidney transplants using TA-NRP DCD allografts have positive short-term mortality and graft survival outcomes, with significantly decreased rates of delayed graft function compared with direct recovery DCD grafts.
胸腹腔亚常温区域灌注(TA-NRP)在美国越来越多地用于循环死亡(DCD)供体的获取。我们报告了使用 TA-NRP 灌注的 DCD 供体移植物进行肾移植的最大结果。
纳入 2020 年至 2022 年期间美国器官共享网络数据库中的成人 DCD 肾移植。在心脏也被移植的情况下,停搏和主动脉阻断时间之间≥50 分钟的供体被认为是 TA-NRP 供体。所有其他供体均被认为是直接回收供体。多变量回归用于评估延迟移植物功能,以及移植后 30、90 和 180 天的移植肾存活率和全因移植物失败。对基于供体肾脏捐赠者概况指数的队列进行了倾向匹配分析。
在所研究期间进行的 16140 例总 DCD 肾移植中,有 306 例(1.9%)使用了 TA-NRP。与直接回收供体相比,TA-NRP 供体更年轻(P<0.001),且肾脏捐赠者概况指数较低(P<0.001)。接受 TA-NRP 回收移植物的受体更年轻(P<0.001),且更可能为血型 O(P<0.001)。使用 TA-NRP 的移植发生延迟移植物功能的可能性较低(调整优势比 0.22[95%置信区间,0.15-0.31],P<0.001),但与使用直接回收移植物的移植相比,180 天存活率(P=0.8)和全因移植物失败率(P=0.3)相似。在倾向匹配分析中,这些推论保持不变。
我们的结果表明,使用 TA-NRP DCD 同种异体移植物进行的肾移植具有积极的短期死亡率和移植物存活率结果,与直接回收 DCD 移植物相比,延迟移植物功能的发生率显著降低。